Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Benapenem in Subjects With Mild or Moderate Renal Impairment
NCT04476407Phase 1Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Jun 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of benapenem in complicated urinary tract infection (cUTI) (3 arms), sponsored by Sihuan Pharmaceutical. Primary endpoints: Area under the plasma concentration-time curve at 72 hours, Maximum observed plasma concentration at 72 hours and 6 more. Started Jun 2019; status: completed.
02
Drugs
benapenem
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT04476407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476407.